Ilka Wicke

Private Equity Investor bei

Boehringer Ingelheim (Venture Capital)

Health Technology

Consumer Services

Finance

Profil

Ilka Wicke is an Investment Manager & Director at Boehringer Ingelheim (Venture Capital) since 2010.
She is also a Director at Pcovery ApS.
Previously, she worked as a Licensing Director at Boehringer Ingelheim GmbH, and as a Director at PROMETHERA Biosciences SA, Cardior Pharmaceuticals GmbH, and AgomAb Therapeutics NV.
Dr. Wicke holds a doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.

Aktive Positionen von Ilka Wicke

Unternehmen	Position	Beginn
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Private Equity Investor	01.01.2010

Alle aktiven Positionen von Ilka Wicke

Ehemalige bekannte Positionen von Ilka Wicke

Unternehmen	Position	Ende
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Direktor/Vorstandsmitglied	06.04.2018
AGOMAB THERAPEUTICS NV	Direktor/Vorstandsmitglied	-
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Direktor/Vorstandsmitglied	-
Boehringer Ingelheim GmbH Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products	Corporate Officer/Principal	-
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Ilka Wicke im Detail an

Ausbildung von Ilka Wicke

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ilka Wicke im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Boehringer Ingelheim GmbH Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products	Health Technology
Johann Wolfgang Goethe-Universität Frankfurt am Main Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Health Technology
Boehringer Ingelheim (Venture Capital) Boehringer Ingelheim (Venture Capital) Investment ManagersFinance BIVF invests in companies located across the globe including the United States, Europe and China. The firm targets companies operating in groundbreaking innovation including cancer, regenerative medicine, auto-immunity indications, digital solutions and infectious disease. It participaotes in seed and early stage capital requirements. The firm acquires minority interest and makes follow-on investments. It also takes seat on the board of directors.	Finance
Pcovery ApS Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections	Health Technology
Cardior Pharmaceuticals GmbH Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Engages in discovery and development of therapies that target RNA as a means to prevent, repair & reverse diseases of the hearts	Health Technology
AgomAb Therapeutics NV AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues	Health Technology